ReP USP - Resultado da busca

Artigo de periodico
Modeling extracellular matrix through histo-molecular gradient in NSCLC for clinical decisions (2022)
Baldavira, Camila Machado ; Prieto, Tabatha Gutierrez; Machado-Rugolo, Juliana; Miranda, Jurandir Tomaz de; Oliveira, Lizandre Keren Ramos de; Velosa, Ana Paula Pereira; Teodoro, Walcy Paganelli Rosolia ; Ab'Saber, Alexandre Muxfeldt; Takagaki, Teresa; Capelozzi, Vera Luiza
Source: Frontiers in oncology. Unidade: FM
Subjects: MATRIZ EXTRACELULAR, NEOPLASIAS PULMONARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BALDAVIRA, Camila Machado et al. Modeling extracellular matrix through histo-molecular gradient in NSCLC for clinical decisions. Frontiers in oncology, v. 12, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/51617. Acesso em: 13 fev. 2026.
APA
Baldavira, C. M., Prieto, T. G., Machado-Rugolo, J., Miranda, J. T. de, Oliveira, L. K. R. de, Velosa, A. P. P., et al. (2022). Modeling extracellular matrix through histo-molecular gradient in NSCLC for clinical decisions. Frontiers in oncology, 12. doi:10.3389/fonc.2022.1042766
NLM
Baldavira CM, Prieto TG, Machado-Rugolo J, Miranda JT de, Oliveira LKR de, Velosa APP, Teodoro WPR, Ab'Saber AM, Takagaki T, Capelozzi VL. Modeling extracellular matrix through histo-molecular gradient in NSCLC for clinical decisions [Internet]. Frontiers in oncology. 2022 ; 12[citado 2026 fev. 13 ] Available from: https://observatorio.fm.usp.br/handle/OPI/51617
Vancouver
Baldavira CM, Prieto TG, Machado-Rugolo J, Miranda JT de, Oliveira LKR de, Velosa APP, Teodoro WPR, Ab'Saber AM, Takagaki T, Capelozzi VL. Modeling extracellular matrix through histo-molecular gradient in NSCLC for clinical decisions [Internet]. Frontiers in oncology. 2022 ; 12[citado 2026 fev. 13 ] Available from: https://observatorio.fm.usp.br/handle/OPI/51617
Artigo de periodico
Clinical outcome of Brazilian patients with non-small cell lung cancer in early stage harboring rare mutations in epidermal growth factor receptor (2022)
Machado-Rugolo, Juliana ; Baldavira, Camila Machado ; Prieto, Tabatha Gutierrez ; Olivieri, E. H. R.; Fabro, Alexandre Todorovic ; Rainho, C. A.; Castelli, E. C.; Ribolla, P. E. M.; Ab'Saber, A. M.; Takagaki, Teresa Yae ; Nagai, M. A.; Capelozzi, Vera Luiza
Source: Brazilian Journal of Medical and Biological Research. Unidades: FMRP, FM
Subjects: CARCINOMA, NEOPLASIAS PULMONARES, FARMACOTERAPIA, MUTAÇÃO GENÉTICA, PROTEÍNAS QUINASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACHADO-RUGOLO, Juliana et al. Clinical outcome of Brazilian patients with non-small cell lung cancer in early stage harboring rare mutations in epidermal growth factor receptor. Brazilian Journal of Medical and Biological Research, v. 55, p. 1-10, 2022Tradução . . Disponível em: https://doi.org/10.1590/1414-431X2022e12409. Acesso em: 13 fev. 2026.
APA
Machado-Rugolo, J., Baldavira, C. M., Prieto, T. G., Olivieri, E. H. R., Fabro, A. T., Rainho, C. A., et al. (2022). Clinical outcome of Brazilian patients with non-small cell lung cancer in early stage harboring rare mutations in epidermal growth factor receptor. Brazilian Journal of Medical and Biological Research, 55, 1-10. doi:10.1590/1414-431X2022e12409
NLM
Machado-Rugolo J, Baldavira CM, Prieto TG, Olivieri EHR, Fabro AT, Rainho CA, Castelli EC, Ribolla PEM, Ab'Saber AM, Takagaki TY, Nagai MA, Capelozzi VL. Clinical outcome of Brazilian patients with non-small cell lung cancer in early stage harboring rare mutations in epidermal growth factor receptor [Internet]. Brazilian Journal of Medical and Biological Research. 2022 ; 55 1-10.[citado 2026 fev. 13 ] Available from: https://doi.org/10.1590/1414-431X2022e12409
Vancouver
Machado-Rugolo J, Baldavira CM, Prieto TG, Olivieri EHR, Fabro AT, Rainho CA, Castelli EC, Ribolla PEM, Ab'Saber AM, Takagaki TY, Nagai MA, Capelozzi VL. Clinical outcome of Brazilian patients with non-small cell lung cancer in early stage harboring rare mutations in epidermal growth factor receptor [Internet]. Brazilian Journal of Medical and Biological Research. 2022 ; 55 1-10.[citado 2026 fev. 13 ] Available from: https://doi.org/10.1590/1414-431X2022e12409
Artigo de periodico
Circulating plasma miRNA and clinical/hemodynamic characteristics provide additional predictive information about acute pulmonary thromboembolism, chronic thromboembolic pulmonary hypertension and idiopathic pulmonary hypertension (2021)
Fabro, Alexandre Todorovic ; Machado-Rugolo, Juliana ; Baldavira, Camila Machado ; Prieto, Tabatha Gutierrez ; Farhat, Cecilia; Mangone, Flavia Regina Rotea; Batah, Sabrina Setembre ; Cruvinel, Heloísa Resende; Alda, Maiara Almeida; Monteiro, Jhonatas Sirino ; Padua, Adriana Inácio de; Morais, Sirlei Siani; Oliveira, Rogério Antônio de ; Santos, Marcel Koenigkam ; Martinez, José Antônio Baddini ; Setubal, João Carlos ; Rainho, Cláudia Aparecida ; Yoo, Hugo Hyung Bok ; Silva, Pedro Leme; Nagai, Maria Aparecida ; Capelozzi, Vera Luiza
Source: Frontiers in Pharmacology. Unidades: FMRP, IQ, FM, Interunidades em Bioinformática
Subjects: MICRORNAS, SEQUENCIAMENTO GENÉTICO, PLASMA, HIPERTENSÃO PULMONAR, TROMBOEMBOLISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FABRO, Alexandre Todorovic et al. Circulating plasma miRNA and clinical/hemodynamic characteristics provide additional predictive information about acute pulmonary thromboembolism, chronic thromboembolic pulmonary hypertension and idiopathic pulmonary hypertension. Frontiers in Pharmacology, v. 12, p. 1-12 art. 648769, 2021Tradução . . Disponível em: https://doi.org/10.3389/fphar.2021.648769. Acesso em: 13 fev. 2026.
APA
Fabro, A. T., Machado-Rugolo, J., Baldavira, C. M., Prieto, T. G., Farhat, C., Mangone, F. R. R., et al. (2021). Circulating plasma miRNA and clinical/hemodynamic characteristics provide additional predictive information about acute pulmonary thromboembolism, chronic thromboembolic pulmonary hypertension and idiopathic pulmonary hypertension. Frontiers in Pharmacology, 12, 1-12 art. 648769. doi:10.3389/fphar.2021.648769
NLM
Fabro AT, Machado-Rugolo J, Baldavira CM, Prieto TG, Farhat C, Mangone FRR, Batah SS, Cruvinel HR, Alda M A, Monteiro JS, Padua AI de, Morais SS, Oliveira RA de, Santos MK, Martinez JAB, Setubal JC, Rainho CA, Yoo HHB, Silva PL, Nagai MA, Capelozzi VL. Circulating plasma miRNA and clinical/hemodynamic characteristics provide additional predictive information about acute pulmonary thromboembolism, chronic thromboembolic pulmonary hypertension and idiopathic pulmonary hypertension [Internet]. Frontiers in Pharmacology. 2021 ; 12 1-12 art. 648769.[citado 2026 fev. 13 ] Available from: https://doi.org/10.3389/fphar.2021.648769
Vancouver
Fabro AT, Machado-Rugolo J, Baldavira CM, Prieto TG, Farhat C, Mangone FRR, Batah SS, Cruvinel HR, Alda M A, Monteiro JS, Padua AI de, Morais SS, Oliveira RA de, Santos MK, Martinez JAB, Setubal JC, Rainho CA, Yoo HHB, Silva PL, Nagai MA, Capelozzi VL. Circulating plasma miRNA and clinical/hemodynamic characteristics provide additional predictive information about acute pulmonary thromboembolism, chronic thromboembolic pulmonary hypertension and idiopathic pulmonary hypertension [Internet]. Frontiers in Pharmacology. 2021 ; 12 1-12 art. 648769.[citado 2026 fev. 13 ] Available from: https://doi.org/10.3389/fphar.2021.648769
Artigo de periodico
Relevance of PD-L1 non-coding polymorphisms on the prognosis of a genetically admixed NSCLC cohort (2021)
Machado-Rugolo, Juliana; Prieto, Tabatha Gutierrez ; Fabro, Alexandre Todorovic ; Cuentas, Edwin Roger Parra; Sá, Vanessa Karen de ; Baldavira, Camila Machado ; Rainho, Cláudia Aparecida; Castelli, Erick da Cruz; Farhat, Cecilia; Takagaki, Teresa Yae; Nagai, Maria Aparecida ; Capelozzi, Vera Luiza
Source: Pharmacogenomics and Personalized Medicine. Unidades: FMRP, FM
Subjects: SEQUENCIAMENTO GENÉTICO, NEOPLASIAS PULMONARES, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACHADO-RUGOLO, Juliana et al. Relevance of PD-L1 non-coding polymorphisms on the prognosis of a genetically admixed NSCLC cohort. Pharmacogenomics and Personalized Medicine, v. 14, p. 239-252, 2021Tradução . . Disponível em: https://doi.org/10.2147/PGPM.S286717. Acesso em: 13 fev. 2026.
APA
Machado-Rugolo, J., Prieto, T. G., Fabro, A. T., Cuentas, E. R. P., Sá, V. K. de, Baldavira, C. M., et al. (2021). Relevance of PD-L1 non-coding polymorphisms on the prognosis of a genetically admixed NSCLC cohort. Pharmacogenomics and Personalized Medicine, 14, 239-252. doi:10.2147/PGPM.S286717
NLM
Machado-Rugolo J, Prieto TG, Fabro AT, Cuentas ERP, Sá VK de, Baldavira CM, Rainho CA, Castelli E da C, Farhat C, Takagaki TY, Nagai MA, Capelozzi VL. Relevance of PD-L1 non-coding polymorphisms on the prognosis of a genetically admixed NSCLC cohort [Internet]. Pharmacogenomics and Personalized Medicine. 2021 ; 14 239-252.[citado 2026 fev. 13 ] Available from: https://doi.org/10.2147/PGPM.S286717
Vancouver
Machado-Rugolo J, Prieto TG, Fabro AT, Cuentas ERP, Sá VK de, Baldavira CM, Rainho CA, Castelli E da C, Farhat C, Takagaki TY, Nagai MA, Capelozzi VL. Relevance of PD-L1 non-coding polymorphisms on the prognosis of a genetically admixed NSCLC cohort [Internet]. Pharmacogenomics and Personalized Medicine. 2021 ; 14 239-252.[citado 2026 fev. 13 ] Available from: https://doi.org/10.2147/PGPM.S286717
Artigo de periodico
In situ evidence of collagen V and interleukin-6/interleukin-17 activation in vascular remodeling of experimental pulmonary hypertension (2020)
Batah, Sabrina Setembre ; Alda, Maiara Almeida; Figueira, Rebeca Rodrigues Lopes Roslindo ; Cruvinel, Heloísa Resende; Silva, Luis Perdoná Rodrigues da; Machado-Rugolo, Juliana ; Velosa, Ana Paula Pereira ; Teodoro, Walcy Paganelli Rosolia ; Balancin, Marcelo Luiz ; Silva, Pedro Leme; Capelozzi, Vera Luiza ; Fabro, Alexandre Todorovic
Source: Pathobiology. Unidades: FM, FMRP, FSP
Subjects: IMUNOFLUORESCÊNCIA, COLÁGENO, INTERLEUCINA 6, HIPERTENSÃO PULMONAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BATAH, Sabrina Setembre et al. In situ evidence of collagen V and interleukin-6/interleukin-17 activation in vascular remodeling of experimental pulmonary hypertension. Pathobiology, v. 87, n. 6, p. 356-366, 2020Tradução . . Disponível em: https://doi.org/10.1159/000510048. Acesso em: 13 fev. 2026.
APA
Batah, S. S., Alda, M. A., Figueira, R. R. L. R., Cruvinel, H. R., Silva, L. P. R. da, Machado-Rugolo, J., et al. (2020). In situ evidence of collagen V and interleukin-6/interleukin-17 activation in vascular remodeling of experimental pulmonary hypertension. Pathobiology, 87( 6), 356-366. doi:10.1159/000510048
NLM
Batah SS, Alda M A, Figueira RRLR, Cruvinel HR, Silva LP R da, Machado-Rugolo J, Velosa APP, Teodoro WPR, Balancin ML, Silva P L, Capelozzi VL, Fabro AT. In situ evidence of collagen V and interleukin-6/interleukin-17 activation in vascular remodeling of experimental pulmonary hypertension [Internet]. Pathobiology. 2020 ; 87( 6): 356-366.[citado 2026 fev. 13 ] Available from: https://doi.org/10.1159/000510048
Vancouver
Batah SS, Alda M A, Figueira RRLR, Cruvinel HR, Silva LP R da, Machado-Rugolo J, Velosa APP, Teodoro WPR, Balancin ML, Silva P L, Capelozzi VL, Fabro AT. In situ evidence of collagen V and interleukin-6/interleukin-17 activation in vascular remodeling of experimental pulmonary hypertension [Internet]. Pathobiology. 2020 ; 87( 6): 356-366.[citado 2026 fev. 13 ] Available from: https://doi.org/10.1159/000510048

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Funding Agencies

Indexado em

Non normalized affiliation